Treatment of non-small cell lung cancer with ifosfamide (IFO)+ 4'-epiadriamycin (EPI)+platinum vs. IFO+EPI: a GETLAC Study. Grupo de Estudio y Tratamiento Latinoamericano del Cáncer Study.

Source:http://linkedlifedata.com/resource/pubmed/id/7800338

Download in:

View as

General Info

PMID
7800338